However, within the myeloma cell compartment, overexpression of IL16 relative to the CD4 receptor is associated with slightly better outcomes in the MMRF CoMMpass dataset (P = 0.038) (Supplementary Fig. 22). This evidence concerns the gene IL16 and plasma cell myeloma.